UK markets closed

Curis, Inc. (CRIS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.72-0.51 (-3.32%)
As of 01:48PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 88.06M
Enterprise value 34.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.89
Price/book (mrq)4.48
Enterprise value/revenue 3.44
Enterprise value/EBITDA -0.76

Trading information

Stock price history

Beta (5Y monthly) 3.76
52-week change 31,802.50%
S&P500 52-week change 321.23%
52-week high 317.49
52-week low 30.38
50-day moving average 311.58
200-day moving average 37.08

Share statistics

Avg vol (3-month) 336.19k
Avg vol (10-day) 326.88k
Shares outstanding 55.89M
Implied shares outstanding 65.89M
Float 84.88M
% held by insiders 10.19%
% held by institutions 136.27%
Shares short (28 Mar 2024) 450.1k
Short ratio (28 Mar 2024) 42.45
Short % of float (28 Mar 2024) 40.85%
Short % of shares outstanding (28 Mar 2024) 40.85%
Shares short (prior month 29 Feb 2024) 456.04k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 330 May 2018
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 330 May 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-452.48%

Management effectiveness

Return on assets (ttm)-32.46%
Return on equity (ttm)-143.19%

Income statement

Revenue (ttm)10.02M
Revenue per share (ttm)1.89
Quarterly revenue growth (yoy)-6.60%
Gross profit (ttm)N/A
EBITDA -48.08M
Net income avi to common (ttm)-47.41M
Diluted EPS (ttm)-8.96
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)56.33M
Total cash per share (mrq)9.56
Total debt (mrq)45.4M
Total debt/equity (mrq)230.81%
Current ratio (mrq)4.51
Book value per share (mrq)3.34

Cash flow statement

Operating cash flow (ttm)-38.43M
Levered free cash flow (ttm)-19.95M